Applicability of Press Needles to a Double-blind Trial A Randomized, Double-blind, Placebo-controlled Trial

被引:23
|
作者
Miyazaki, Shougo
Hagihara, Akihito [1 ]
Kanda, Ryo [2 ]
Mukaino, Yoshito [2 ]
Nobutomo, Koichi
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Serv Management & Policy, Higashi Ku, Fukuoka 8128582, Japan
[2] Fukuoka Univ, Fac Sports & Hlth Sci, Fukuoka 81401, Japan
来源
CLINICAL JOURNAL OF PAIN | 2009年 / 25卷 / 05期
关键词
placebo; press needle; double-blind method; low back pain; randomized controlled trial; LOW-BACK-PAIN; NOXIOUS INHIBITORY CONTROLS; ACUPUNCTURE TRIALS; JAPANESE VERSION; ADVERSE EVENTS; OSTEOARTHRITIS; MIGRAINE; KNEE; QUESTIONNAIRE; MOXIBUSTION;
D O I
10.1097/AJP.0b013e318193a6e1
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Owing to a lack of a suitable needle procedure, it has been impossible to evaluate the efficacy of acupuncture in clinical studies using double-blind testing. We evaluated the applicability of a new kind of press needle (Pyonex) to a double-blind trial by comparing the press needle with a placebo (lacking the needle element). Methods: The purpose of the study consisted of 2 phases. In the phase 1, to evaluate the applicability and efficacy of the press needles, 90 participants who had never been treated using acupuncture were randomly assigned to receive either the press needle (n = 45) or a placebo (n = 45). The applicability was measured using a questionnaire regarding the perception of penetration, and efficacy was measured using a visual analog scale of low back pain (LBP). When the applicability and efficacy of the press needles were confirmed in phase 1, the mechanism of LBP relief by the press needles was examined in phase 2. Results: In phase 1, intergroup comparisons showed no significant differences concerning the perception of penetration. In addition, for patients with LBP, the press needles reduced the subjective evaluation of LBP compared with the placebo (P < 0.05). In phase 2, visual analog scale results indicated that LBP was reduced significantly more in the press needle group than in the local anesthesia group (P < 0.05). Discussion: The participants could not distinguish between the press needle and a placebo, and the data from the press needle group suggested a specific influence on patients with LBP. These findings imply that the press needle and a placebo provide an effective means of realizing a double-blind setting for clinical studies of acupuncture.
引用
收藏
页码:438 / 444
页数:7
相关论文
共 50 条
  • [1] Double-blind randomized placebo-controlled trial of sibutramine
    Bray, GA
    Ryan, DH
    Gordon, D
    Heidingsfelder, S
    Cerise, F
    Wilson, K
    [J]. OBESITY RESEARCH, 1996, 4 (03): : 263 - 270
  • [2] The cult of the double-blind placebo-controlled trial
    Ellis, SJ
    Adams, RF
    [J]. BRITISH JOURNAL OF CLINICAL PRACTICE, 1997, 51 (01): : 36 - 39
  • [3] Marfan Sartan: a randomized, double-blind, placebo-controlled trial
    Milleron, Olivier
    Arnoult, Florence
    Ropers, Jacques
    Aegerter, Philippe
    Detaint, Delphine
    Delorme, Gabriel
    Attias, David
    Tubach, Florence
    Dupuis-Girod, Sophie
    Plauchu, Henry
    Barthelet, Martine
    Sassolas, Francois
    Pangaud, Nicolas
    Naudion, Sophie
    Thomas-Chabaneix, Julie
    Dulac, Yves
    Edouard, Thomas
    Wolf, Jean-Eric
    Faivre, Laurence
    Odent, Sylvie
    Basquin, Adeline
    Habib, Gilbert
    Collignon, Patrick
    Boileau, Catherine
    Jondeau, Guillaume
    [J]. EUROPEAN HEART JOURNAL, 2015, 36 (32) : 2160 - U37
  • [4] A double-blind, randomized, placebo-controlled laser trial methodology
    Oussedik, E.
    Saleem, M. D.
    Patel, N. U.
    Feldman, S. R.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : B11 - B11
  • [5] A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza
    Latte, J
    Taverner, D
    Slobodian, P
    Shakib, S
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (07): : 429 - 432
  • [6] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF KETAZOLAM IN ANXIETY
    BOWDEN, CL
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1978, 24 (02): : 170 - 178
  • [7] BROMOCRIPTINE IN MANIA - PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL
    SMITH, AHW
    CHAMBERS, C
    NAYLOR, GJ
    [J]. BRITISH MEDICAL JOURNAL, 1980, 280 (6207): : 86 - 86
  • [8] NIFEDIPINE FOR EPILEPSY - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    LARKIN, JG
    BESAG, FMC
    COX, A
    WILLIAMS, J
    BRODIE, MJ
    [J]. EPILEPSIA, 1992, 33 (02) : 346 - 352
  • [9] A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
    Turner, R. Scott
    Thomas, Ronald G.
    Craft, Suzanne
    van Dyck, Christopher H.
    Mintzer, Jacobo
    Reynolds, Brigid A.
    Brewer, James B.
    Rissman, Robert A.
    Raman, Rema
    Aisen, Paul S.
    [J]. NEUROLOGY, 2015, 85 (16) : 1383 - 1391
  • [10] Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial
    Khan, AA
    Bilezikian, JP
    Kung, AWC
    Ahmed, MM
    Dubois, SJ
    Ho, AYY
    Schussheim, D
    Rubin, MR
    Shaikh, AM
    Silverberg, SJ
    Standish, TI
    Syed, Z
    Syed, ZA
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (07): : 3319 - 3325